AI meets antibody design: Galux draws $29M series B for drug R&D
Article Title: “AI meets antibody design: Galux draws $29M series B for drug R&D” Publication Date: February 10, 2026 On February 10, 2026, Galux, the pioneer in AI-driven antibody design, announced closing a $29 million series B round. In a…